#DMARDs

Springer Medicine

@springermedicine.com

2 months ago

#MedPodcast - Prof. Ali Mobasheri identifies the key issues in developing a successful disease-modifying #osteoarthritis drug and how they can be overcome.

Listen now 🔉 buff.ly/fZhg0kY

#DMARDs

Prkash Mishra

@iprkashmishra.bsky.social

4 months ago

#Arthritis30
#Osteoarthritis #RheumatoidArthritis #Spondyloarthritis #SeronegativeArthritis #JointPain #AutoimmuneDisease #Inflammation #Orthopedics #Rheumatology #HeberdenNodes #BouchardNodes #SwanNeckDeformity #BoutonniereDeformity #HLA_B27 #DMARDs #NSAIDs #Methotrexate #JointHealth

@clin-med.bsky.social

5 months ago

"The true beauty of medicine lies in lifelong learning and reflection"

This issue's editorial explores #CME #rheumatology #gout #SLE #DMARDs and much, much more ⬇️

www.sciencedirect.com/science/article/pii/S147...

Thiard News@F4F

@newsen.bsky.social

5 months ago

Rheumatoid Arthritis Drug Market Set to Soar to $56.62 Billion by 2033, Driven by Innovation and Awareness The global market for rheumatoid arthritis drugs is projected to expand significantly, reaching $56.62 billion by 2033, reflecting a CAGR of 6.8%. This growth is spurred by increased awareness and advancements in treatment strategies.

Rheumatoid Arthritis Drug Market Set to Soar to $56.62 Billion by 2033, Driven by Innovation and Awareness #USA #Austin #Biologics #rheumatoid_arthritis #DMARDs

Springer Medicine

@springermedicine.com

5 months ago

Vaccination Update and Specific Concerns for RA Comprehensive and up-to-date evidence on the effectiveness and safety of vaccines in people with rheumatoid arthritis and the impact of DMARDs, as well as recommendations regarding the optimal use of…

Explore comprehensive and up-to-date evidence on the effectiveness and safety of #vaccines in people with rheumatoid #arthritis and the impact of #DMARDs, as well as recommendations regarding the optimal use of vaccines in these patients.

👉 buff.ly/LCHRrwk

#RheumSky #IDSky

Springer Medicine

@springermedicine.com

5 months ago

Uncertainty over need for early biologic DMARD addition to methotrexate in psoriatic arthritis In untreated patients with a recent psoriatic arthritis diagnosis, methotrexate alone or combined with golimumab significantly reduces disease activity.

#MedNews - In untreated patients with a recent #PsoriaticArthritis diagnosis, #methotrexate alone or combined with #golimumab significantly reduces disease activity.

Full story 👉 buff.ly/H7q2qK0

#RheumTwitter #DMARDs

@rcatanho.bsky.social

6 months ago

Long-Term Routine Laboratory Toxicity Monitoring of Immunomodulatory Drugs in Rheumatoid Arthritis: A Retrospective Cohort Study: Annals of Internal Medicine: Vol 0, No 0 Background: Scarcity of data on the value of long-term routine laboratory toxicity monitoring (lt-RLTM) during disease-modifying antirheumatic drug (DMARD) use results in frequent monitoring in clinic...

Resultados muy anormales de laboratorio con antirreumáticos modificadores de la enf se anticipan clínicamente y a menudo ocurren luego de escalar la dosis, aunque la incidencia acumulativa de los resultados menos graves es bastante alta #toxicity #DMARDS #RA. www.acpjournals.org/doi/10.7326/...

Anaya Malik

@amjeditor.bsky.social

8 months ago

Rheumatoid Arthritis Therapy Hinges on Infection Check Thorough screening for latent TB, hepatitis B, and hepatitis C before b/tsDMARD therapy in RA patients improves safety and outcomes, especially in high-burden regions, audit shows.

🦠 Patients with RA on biologics need infection screening first!
Audit finds missed tests for TB, Hep B & C before starting DMARDs.
Missed checks = patient risk.
📖 www.emjreviews.com/en-us/amj/rh...
#AMJRheumatology #PatientSafety #DMARDs

SQUEEZE project

@squeezeproject.bsky.social

9 months ago

🖼️ Posters, posters, posters! Join us on Day 2 of #EULAR2025 in the poster area 📍and learn more about the work of @agneskocher2.bsky.social and further SQUEEZE experts on #adherence, the Torque Teno Virus #TTV 🦠, user-friendly web tools, and the choice and effectiveness of second #DMARDs.

ndosie.bsky.social

@ndosie.bsky.social

10 months ago

Exploring the perspective of patients with immune-mediated inflammatory diseases and care providers on the use of immunomodulatory drugs in infections: an interview study AbstractObjectives. Immunomodulatory agents are safe and effective as treatment for various immune-mediated inflammatory diseases (IMIDs), but are associat

Should people with inflammatory #arthritis stay on #DMARDs therapy during infections?

Qualitative data from interviews with patients and clinicians show 10 key themes (e.g. trust, disease activity, infection type) guide shared decision-making

@rheumjnl.bsky.social doi.org/10.1093/rap/...

ndosie.bsky.social

@ndosie.bsky.social

10 months ago

Flow diagram from included patients to patients with serious infection. Temporary interruption or continuation of IA resulted in similar outcome of infections. These findings suggest that continuation of IA is safe, although precision was somewhat limited due to low event rates. Data presented at EULAR 2024 by Opdam M, Den Broeder N, Van Crevel R, et al Ann Rheum Dis 2024;83:1156-1157. https://doi.org/10.1136/annrheumdis-2024-eular.5332

Can people with inflammatory #arthritis safely stay on disease-modifying antirheumatic drugs #DMARDs during infections?

📊 RCT data show no increased risk of serious infections in continuing DMARDs

⚠️ Challenges traditional approach to pause treatment

🇳🇱 #RA #PsA #AxSpA 🔗 doi.org/10.1136/annr...